Intern II - Global Marketing jobs in United States
cer-icon
Apply on Employer Site
company-logo

Dexcom · 1 day ago

Intern II - Global Marketing

Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring. The Intern II in Global Marketing will work on impactful projects that support people living with diabetes, focusing on competitive analysis, marketing claims, and campaign support.

DiabetesHealth DiagnosticsMedical DeviceSensor
check
H1B Sponsor Likelynote

Responsibilities

Conduct competitive analysis for upcoming features or product releases to inform creative positioning
Create compelling marketing claims and help drive internal approvals (Veeva experience a plus!)
Support the production of a global TVC campaign
Support international event production

Qualification

Competitive analysisMarketing claims creationVeeva experienceEvent productionInitiative & curiosityOrganizedCollaborative mindsetStrategic thinkerDetail-oriented

Required

Requires a completed Bachelor's degree
Must be a currently enrolled Master's, JD, or PhD student at an accredited college or university with an expected graduation date of December 2026 or later

Preferred

Veeva experience a plus!

Benefits

Participation in a targeted Learning Series that encourages professional development topics and provides insight into Dexcom's culture and career opportunities.
Engagement in Social Events, Intern Recognition Awards, Paid Holidays, and more!

Company

Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.

H1B Sponsorship

Dexcom has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (41)
2023 (67)
2022 (75)
2021 (49)
2020 (36)

Funding

Current Stage
Public Company
Total Funding
$2.16B
Key Investors
RWI Group
2023-05-02Post Ipo Debt· $1B
2020-05-12Post Ipo Debt
2018-11-01Post Ipo Equity· $750M

Leadership Team

leader-logo
Jacob Leach
Chief Operating Officer
linkedin
leader-logo
Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs
linkedin
Company data provided by crunchbase